News Releases

Targeting HIV: Moving closer to a potential cure


Tri-specific antibody targets and neutralizes 99.5% of HIV-1 virus strains

(Rockville, MD, March 13, 2018) A team of researchers at IBBR, led by Dr. Yuxing Li, Associate Professor at the University of Maryland School of Medicine, Baltimore, and Principal Investigator at the Institute for Bioscience and Biotechnology Research (IBBR), Rockville, is showing how engineered multi-specific antibodies appear to be highly effective at preventing infection across a broad range of HIV-1 virus strains.

Dr. Gregory Payne and Team Nominated for the UMD Invention of the Year Award


March 8, 2018 -- Each year, UMD honors exceptional inventions that have the potential to influence science, society, and the free market. Dr. Gregory Payne, Professor, IBBR, and his research team, have been nominated in the Physical Sciences category for their project:   Transformational Electronic Tool for Chemical Analysis:  Oxidative Stress Detection. 

IBBR awarded DOE grant to investigate how to protect an emerging biofuel crop from disease


UMD researchers work to defend poplar trees – a promising resource for renewable and sustainable energy – from leaf rust and other diseases

(Rockville, MD, January 29, 2018)  The Institute for Bioscience and Biotechnology Research (IBBR) has been awarded a $1.1M U.S. Department of Energy grant to elucidate the mechanism of rust pathogenesis in poplar in an effort to engineer durable resistance for this important, second generation biofuel crop.  The collaborative, multidisciplinary research is led by Dr. Edward Eisenstein, IBBR Fellow and Associate Professor,... Read More

Expanding Partnership between University of Maryland and East China University of Science and Technology


January 25, 2018 -- The new year is off to a great start for the partnership between University of Maryland (UMD) and Shanghai’s East China University of Science and Technology (ECUST).  The goal of this partnership has been to integrate UMD’s expertise in biofabrication with ECUST’s translational research in biomedical materials.  On January 8, 2018, UMD-ECUST hosted their first graduate student Elevator Pitch competition. 

IBBR High School Intern Sarah Gao Named Regeneron Science Talent Search Finalist


Sarah Gao to Compete for Top Awards in Most Prestigious U.S. Science and Mathematics Competition for High School Seniors

(Rockville, MD., January 25, 2018) Sarah Gao, a senior at Montgomery Blair High School in Silver Spring, MD, and a research intern at the University of Maryland Institute for Bioscience and Biotechnology Research (IBBR) in Rockville, MD, has been named a finalist in the Regeneron Science Talent Search, the nation’s oldest and most prestigious science and math competition for high school seniors.

IBBR awarded NIH grant to investigate body’s T-cell mechanism of attack


New approaches hope to give researchers a glimpse into the cell’s “alert system” to fight tumors and viruses

(Rockville, MD, December 13, 2017)  A new research initiative by the Institute for Bioscience and Biotechnology Research (IBBR) and the University of Pittsburgh could finally uncover how T-cells—the “killer cells” that defend the body from microbes—are alerted to hazardous invaders in the body.  Funded by a $3.7 million grant from the National Institutes of Health (NIH), the research will be the first to combine X-ray crystallography and... Read More

NIST-IBBR Researchers Awarded Department of Commerce Gold Medal for developing the NISTmAb Standard


October 11, 2017 -- NIST-IBBR scientists receive a 2017 Department of Commerce (DOC) Gold Medal Award, the highest honor award bestowed by the United States Department of Commerce.  John Schiel, Abigail Turner and Catherine Mouchahoir were recognized with their NIST colleagues Srivalli Telikepalli and Paul Derose for developing NISTmAb, industry’s first monoclonal antibody reference material and benchmarking tool for the manufacturing of life-saving protein drugs.  

IBBR Receives Grant to Explore Next Generation Multi-Specific Antibody Therapeutic: Next Step towards a Cure for HIV?


The goal is to develop and test a “first-in-class multi-specific antibody“, which could offer dramatic advantages over current treatments for AIDS patients, help eliminate hidden reservoirs of HIV, and potentially deliver on the promise of a long-awaited HIV cure.

(Rockville, MD, September 5, 2017) The Institute for Bioscience and Biotechnology Research (IBBR) has been awarded a $115,000 grant to further develop and commercialize a multi-specific antibody as a therapeutic for HIV.  The grant is funded under the Maryland Innovation Initiative (MII) by the Maryland... Read More

Montgomery County High School Interns Showcase Their Achievements


August 21, 2017 -- The University of Maryland Institute for Bioscience and Biotechnology Research (IBBR) solicits applications each year for summer and year-long internships open to Montgomery County high school juniors (age 16 and over). On Wednesday, August 16, this year’s summer interns presented their findings via posters they created, as IBBR faculty, post-doctoral fellows, graduate students and staff talked with them about what they had learned. 

Exploring Biomedical Applications of Multifunctional Polyphosphazenes


Renowned IBBR chemist to speak at the American Chemical Society National Meeting

(Rockville, MD, August 16, 2017) Alexander K. Andrianov, Ph.D., Research Professor at the University of Maryland’s Institute for Bioscience and Biotechnology Research (IBBR), whose research led to the formation of Innovo Biopolymers LLC, is a co-organizer of a “Polyphosphazenes in Biomedicine, Engineering & Pioneering Synthesis” Symposium at the 254th American Chemical Society (ACS) Meeting, scheduled for August 20-24, 2017, in Washington, DC.